Long-term Effect of CPAP Treatment on Cardiovascular Events in Patients With Resistant Hypertension and Sleep Apnea. Data From the HIPARCO-2 Study
Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):165-171.
doi: 10.1016/j.arbres.2019.12.006.
Epub 2020 Feb 3.
[Article in
English,
Spanish]
Authors
Cristina Navarro-Soriano
1
, Miguel-Angel Martínez-García
2
, Gerard Torres
3
, Ferrán Barbé
4
, Manuel Sánchez-de-la-Torre
5
, Candela Caballero-Eraso
6
, Patricia Lloberes
7
, Trinidad Díaz Cambriles
8
, María Somoza
9
, Juan F Masa
10
, Mónica González
11
, Eva Mañas
12
, Mónica de la Peña
13
, Francisco García-Río
14
, Josep María Montserrat
15
, Alfonso Muriel
16
, Grace Oscullo
1
, Alberto García-Ortega
1
, Tomás Posadas
1
, Francisco Campos-Rodríguez
17
; on behalf the Spanish Sleep Network
Affiliations
- 1 Pneumology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
- 2 Pneumology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Electronic address: mianmartinezgarcia@gmail.com.
- 3 Internal Medicine Service, Hospital Universitari de Santa María, Lleida, Spain.
- 4 Group of Traslational Research in Respiratory Medicine, Hospital Arnau de Vilanova-Santa Maria, IRBLleida, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 5 Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Group of Precision Medicine in Chronic Diseases, Hospital Arnau de Vilanova-Santa Maria, IRBLleida, Lleida, Spain.
- 6 Respiratory Department, Hospital Universitario Virgen del Rocío, Institute of Biomedicine of Seville (IBiS), Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 7 Respiratory Department, Hospital Universitario Vall Hebrón, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 8 Respiratory Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
- 9 Respiratory Department, Consorcio Sanitario de Terrassa, Barcelona, Spain.
- 10 Respiratory Department, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 11 Respiratory Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
- 12 Respiratory Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
- 13 Respiratory Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
- 14 Respiratory Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 15 Respiratory Department, Hospital Clinic-IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 16 Biostatistic Unit, Hospital Universitario Ramón y Cajal, IRYCIS, CIBERESP, Madrid, Spain.
- 17 Respiratory Department, Hospital Universitario Valme, Institute of Biomedicine of Seville (IBiS), Sevilla, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Abstract
Background:
There is some controversy about the effect of continuous positive airway pressure (CPAP) on the incidence of cardiovascular events (CVE). However, the incidence of CVE among patients with both obstructive sleep apnea (OSA) ans resistant hypertension (HR) has not been evaluated. Our objective was to analyze the long-term effect of CPAP treatment in patients with RH and OSA on the incidence of CVE.
Methods:
Multi-center, observational and prospective study of patients with moderate-severe OSA and RH. All the patients were followed up every 3-6 months and the CVE incidence was measured. Patients adherent to CPAP (at least 4h/day) were compared with those with not adherent or those who had not been prescribed CPAP.
Results:
Valid data were obtained from 163 patients with 64 CVE incidents. Treatment with CPAP was offered to 82%. After 58 months of follow-up, 58.3% of patients were adherent to CPAP. Patients not adherent to CPAP presented a non-significant increase in the total CVE incidence (HR:1.6; 95%CI: 0.96-2.7; p=0.07). A sensitivity analysis showed that patients not adherent to CPAP had a significant increase in the incidence of cerebrovascular events (HR: 3.1; CI95%: 1.07-15.1; p=0.041) and hypertensive crises (HR: 5.1; CI95%: 2.2-11.6; p=0.006), but the trend went in the opposite direction with respect to coronary events (HR: 0.22; CI95%: 0.05-1.02; p=0.053).
Conclusions:
In patients with RH and moderate-severe OSA, an uneffective treatment with CPAP showed a trend toward an increase in the incidence of CVE (particularly neurovascular events and hypertensive crises) without any changes with respect to coronary events.
Keywords:
Accidente cerebrovascular; Apnea del sueño; CPAP; Cardiovascular events; Cerebrovascular disease; Coronary heart disease; Enfermedad cerebrovascular; Enfermedad coronaria; Eventos cardiovasculares; Hipertensión resistente; Presión positiva continua en las vías respiratorias; Resistant hypertension; Sleep apnea; Stroke.
Copyright © 2021. Publicado por Elsevier España, S.L.U.
Publication types
-
Multicenter Study
-
Observational Study
MeSH terms
-
Continuous Positive Airway Pressure
-
Humans
-
Hypertension* / epidemiology
-
Prospective Studies
-
Sleep Apnea Syndromes*
-
Sleep Apnea, Obstructive* / epidemiology